Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) (Q70542302)
Jump to navigation
Jump to search
scientific article published on 01 February 1993
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) |
scientific article published on 01 February 1993 |
Statements
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) (English)
J P Gendre
J Y Mary
C Florent
R Modigliani
J F Colombel
J C Soulé
J P Galmiche
E Lerebours
L Descos
1 February 1993